The derivative exchange Bitget issued a statement saying, “a recent report by the Financial Times claiming the platform was suspended from operation in Singapore for being mired in a row involving K-pop band BTS was inaccurate. ” Bitget points out that such an incorrect report is highly misleading as it has delivered the false message to its users, partners, and the broader media community.
12-15
The derivative exchange Bitget issued a statement saying, “a recent report by the Financial Times claiming the platform was suspended from operation in Singapore for being mired in a row involving K-pop band BTS was inaccurate. ” Bitget points out that such an incorrect report is highly misleading as it has delivered the false message to its users, partners, and the broader media community.
12-10
11-30
DBL (Diamond Bull Limited) is a global leading venture capital and asset management organization, specializing in frontier fields such as metaverse, blockchain, AR, VR, artificial intelligence and big data. DBL has started large-scale investment in the current hot field of chain games and blockchain, and has cooperated with excellent communities in Europe and the United States, South Korea and Japan to carry out the layout of chain games. It cooperates with the world's top guild teams in the secondary market to build a unique AB-NFT investment strategy for NFT investors.
11-28
Today's global technology is changing more than you can imagine, the Blockchain decentralized network aggregator financial TRX-PNFT meta-universe ecology, chain tour development.
11-27
11-26
In the past six months, NFT, the concept of meta-universe, has opened up a vast imagination for blockchain. With Facebook renamed Meta, investors are increasingly curious about what the future meta-universe will actually look like.
11-24
11-22
11-18
Secure, easy-to-use multichain wallet powered by DAMNCool Ecosystem
11-17
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map